Cargando…

NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy

Diabetic cardiomyopathy (DCM), a common consequence of longstanding diabetes mellitus, is initiated by death of cardiomyocyte. Hyperglycemia-induced reactive oxygen species (ROS) overproduction is a major contributor of the chronic low-grade inflammation that characterizes as the DCM. ROS may promot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Beibei, Huang, Feng, Liu, Yanli, Liang, Yiying, Wei, Zhe, Ke, Honghong, Zeng, Zhiyu, Huang, Weiqiang, He, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524816/ https://www.ncbi.nlm.nih.gov/pubmed/28790925 http://dx.doi.org/10.3389/fphys.2017.00519

Ejemplares similares

Chemerin/CMKLR1 Axis Promotes Inflammation and Pyroptosis by Activating NLRP3 Inflammasome in Diabetic Cardiomyopathy Rat
por: Xie, Yebin, et al.
Publicado: (2020)

The Role of the NLRP3 Inflammasome in Mediating Glomerular and Tubular Injury in Diabetic Nephropathy
por: Williams, B. M., et al.
Publicado: (2022)

NLRP3 Inflammasome in Diabetic Cardiomyopathy and Exercise Intervention
por: Sun, Yi, et al.
Publicado: (2021)

Inflammation triggered by the NLRP3 inflammasome is a critical driver of diabetic bladder dysfunction
por: Hughes, Francis M., et al.
Publicado: (2022)

The Role of NLRP3 Inflammasome in Diabetic Cardiomyopathy and Its Therapeutic Implications
por: Ding, Kai, et al.
Publicado: (2022)

The NLRP3 Inflammasome: Role and Therapeutic Potential in Pain Treatment
por: Starobova, Hana, et al.
Publicado: (2020)

Gypenosides improve diabetic cardiomyopathy by inhibiting ROS‐mediated NLRP3 inflammasome activation
por: Zhang, Hailong, et al.
Publicado: (2018)

DsbA-L Ameliorates Renal Injury Through the AMPK/NLRP3 Inflammasome Signaling Pathway in Diabetic Nephropathy
por: Yang, Ming, et al.
Publicado: (2021)

Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications
por: Sharma, Arpeeta, et al.
Publicado: (2018)

Mitochondrial DNA Promotes NLRP3 Inflammasome Activation and Contributes to Endothelial Dysfunction and Inflammation in Type 1 Diabetes
por: Pereira, Camila A., et al.
Publicado: (2020)

Aerobic exercise alleviates pyroptosis-related diseases by regulating NLRP3 inflammasome
por: Hu, Shujuan, et al.
Publicado: (2022)

Inflammation and oxidative stress in salt sensitive hypertension; The role of the NLRP3 inflammasome
por: Ertuglu, Lale A., et al.
Publicado: (2022)

Suppression of Glucagon-Like Peptide-1 Release by Inhibition of Intestinal NLRP3 Inflammasome Activation in Asc(–/–) and Nlrp3(–/–) Mice
por: Chen, Yu, et al.
Publicado: (2019)

NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy
por: Zeng, Cheng, et al.
Publicado: (2020)

Trimethylamine N-Oxide Exacerbates Cardiac Fibrosis via Activating the NLRP3 Inflammasome
por: Li, Xueling, et al.
Publicado: (2019)

Calcium-sensing receptor-mediated NLRP3 inflammasome activation in rheumatoid arthritis and autoinflammation
por: Werner, Lina Emilia, et al.
Publicado: (2023)

NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy
por: Zhang, Lixia, et al.
Publicado: (2022)

New Molecular Insights of Insulin in Diabetic Cardiomyopathy
por: Westermeier, Francisco, et al.
Publicado: (2016)

Cardiomyocyte Inflammasome Signaling in Cardiomyopathies and Atrial Fibrillation: Mechanisms and Potential Therapeutic Implications
por: Chen, Gong, et al.
Publicado: (2018)

Shikonin Ameliorates LPS-Induced Cardiac Dysfunction by SIRT1-Dependent Inhibition of NLRP3 Inflammasome
por: Guo, Tao, et al.
Publicado: (2020)

Novel Insights Into Molecular Mechanism of Mitochondria in Diabetic Cardiomyopathy
por: Bai, Jing, et al.
Publicado: (2021)

Reactive Oxygen Species Interact With NLRP3 Inflammasomes and Are Involved in the Inflammation of Sepsis: From Mechanism to Treatment of Progression
por: Zhao, Shuai, et al.
Publicado: (2020)

HMGB1 Increases IL-1β Production in Vascular Smooth Muscle Cells via NLRP3 Inflammasome
por: Kim, Eun Jung, et al.
Publicado: (2018)

Krill Oil Inhibits NLRP3 Inflammasome Activation in the Prevention of the Pathological Injuries of Diabetic Cardiomyopathy
por: Sun, Xuechun, et al.
Publicado: (2022)

Research progress on the activation mechanism of NLRP3 inflammasome in septic cardiomyopathy
por: Wen, Yuqi, et al.
Publicado: (2023)

Diabetic Cardiomyopathy: Impact of Biological Sex on Disease Development and Molecular Signatures
por: Toedebusch, Ryan, et al.
Publicado: (2018)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023)

Expression and clinical value of NLRP1 and NLRC4 inflammasomes in prostate cancer
por: Liang, Ke, et al.
Publicado: (2023)

Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy
por: Yang, Fan, et al.
Publicado: (2019)

Aloe-Emodin Derivative, an Anthraquinone Compound, Attenuates Pyroptosis by Targeting NLRP3 Inflammasome in Diabetic Cardiomyopathy
por: Hu, Yingying, et al.
Publicado: (2023)

Cyclic Stretch Negatively Regulates IL-1β Secretion Through the Inhibition of NLRP3 Inflammasome Activation by Attenuating the AMP Kinase Pathway
por: Maruyama, Kentaro, et al.
Publicado: (2018)

The Role of Sodium in Diabetic Cardiomyopathy
por: Doliba, Nicolai M., et al.
Publicado: (2018)

The Role of Leukocytes in Diabetic Cardiomyopathy
por: Bajpai, Anamika, et al.
Publicado: (2018)

Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes
por: Ding, Sujuan, et al.
Publicado: (2019)

NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
por: Luo, Beibei, et al.
Publicado: (2014)

Pyroptosis and Its Regulation in Diabetic Cardiomyopathy
por: Lu, Yafang, et al.
Publicado: (2022)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

Left Ventricular Wall Stress Is Sensitive Marker of Hypertrophic Cardiomyopathy With Preserved Ejection Fraction
por: Zhao, Xiaodan, et al.
Publicado: (2018)

Dapagliflozin protects against dilated cardiomyopathy progression by targeting NLRP3 inflammasome activation
por: Hu, Jiaxin, et al.
Publicado: (2023)

Oroxylin A inhibits colitis by inactivating NLRP3 inflammasome
por: Zhou, Wei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mpaqj97kgrnviddk0l451abves